Navigation Links
Prolia® (Denosumab) Phase 2 Extension Study Showed Continued Increase in Bone Mineral Density Over Eight Years of Treatment
Date:9/17/2011

in significant suppression of bone remodeling. The significance of these findings is unknown. The long-term consequences of the degree of suppression of bone remodeling observed with Prolia may contribute to adverse outcomes such as osteonecrosis of the jaw (ONJ), atypical fractures and delayed fracture healing. ONJ has been reported in patients with Prolia. Patients should be monitored for these adverse outcomes. The most common adverse reactions (> 5 percent and more common than placebo) were back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia and cystitis. Pancreatitis has also been reported with Prolia.

Important EU Safety Information

The most common adverse reactions with Prolia were urinary tract infection, upper respiratory tract infection, sciatica, cataracts, constipation, rash and pain in extremity. The most serious adverse reactions were those of skin infections, predominantly cellulitis, reported more commonly in the Prolia group compared with placebo (0.4 percent vs. 0.1 percent) in postmenopausal osteoporosis studies. In breast and prostate cancer studies, serious adverse reactions of skin infection were similar in the Prolia and placebo groups (0.6 percent vs. 0.6 percent). In the Phase 3 placebo-controlled clinical trial in patients with prostate cancer receiving ADT, an imbalance in cataract adverse events was observed with Prolia compared with placebo (4.7 percent vs. 1.2 percent placebo). No imbalance in cataract adverse events was observed in postmenopausal women with osteoporosis or in women undergoing aromatase inhibitor therapy for nonmetastatic breast cancer.

Prolia may lead to hypocalcaemia. Hypocalcaemia must be corrected by adequate intake of calcium and vitamin D before initiating therapy. ONJ has been reported rarely in clinical studies in patients receiving denosumab at a dose of 60 mg every 6 months for osteoporosis.

Denosumab Commercialization Collaborations

I
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate
2. Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Five Years of Treatment With Similar Safety Profile Observed in Pivotal Trial
3. XGEVA® (Denosumab) Granted Marketing Authorization in the European Union
4. Amgen Receives CHMP Positive Opinion for XGEVA™ (Denosumab) in the European Union
5. Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer
6. The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma
7. XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer
8. Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS
9. Prolia™ (denosumab) Receives Best New Drug Honor at Scrip Awards
10. Vantage Health Announces That All of Its Required Tanzanian Registrations, Permits and Licenses Have Been Formally Issued, Simultaneous With Official Notification That Its Application for Phase One Evaluation of Its HIV Screening Test Kits Has Been
11. Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 23, 2013  Hadasit Bio-Holdings Ltd. (TASE: HDST, ... companies, based on intellectual property developed and owned ... ,s foremost medical research center, today announced that ... significant funding from the Israeli Ministry of Industry ... to support product development and advance clinical trials. ...
(Date:5/23/2013)... 23, 2013 Anthem Blue Cross patients with ... required them to obtain their medications by mail order ... Whatley Kallas LLC.  The lawsuit, filed ... Blue Cross,s mandatory mail order program announced late last ... privacy. "This settlement brings to a close ...
(Date:5/23/2013)... , May 23, 2013  Hologic, Inc. (Hologic ... a leading developer, manufacturer and supplier of premium ... an emphasis on serving the healthcare needs of ... study in a U.S. clinical practice comparing breast ... tomosynthesis) with conventional 2D mammography alone showed a ...
Breaking Medicine Technology:Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4
... a new market research report is available in its catalogue: , ... Western European Disinfectant Gels and Scrubs Market , ... http://www.reportlinker.com/p0239932/Western-European-Disinfectant-Gels-and-Scrubs-Market.html , , , ... and scrubs market in western Europe , covering the United Kingdom , ...
... N.C. , July 19 Allscripts (Nasdaq: ... system in western North Carolina , has selected Allscripts Electronic ... its 60 employed physicians.  MedWest is also planning to host and deliver ... it serves. , , , ...
Cached Medicine Technology:Reportlinker Adds Western European Disinfectant Gels and Scrubs Market 2Reportlinker Adds Western European Disinfectant Gels and Scrubs Market 3Reportlinker Adds Western European Disinfectant Gels and Scrubs Market 4Reportlinker Adds Western European Disinfectant Gels and Scrubs Market 5Reportlinker Adds Western European Disinfectant Gels and Scrubs Market 6MedWest Health System Selects Allscripts Electronic Health Record and Practice Management for Employed Physicians 2MedWest Health System Selects Allscripts Electronic Health Record and Practice Management for Employed Physicians 3MedWest Health System Selects Allscripts Electronic Health Record and Practice Management for Employed Physicians 4MedWest Health System Selects Allscripts Electronic Health Record and Practice Management for Employed Physicians 5MedWest Health System Selects Allscripts Electronic Health Record and Practice Management for Employed Physicians 6MedWest Health System Selects Allscripts Electronic Health Record and Practice Management for Employed Physicians 7MedWest Health System Selects Allscripts Electronic Health Record and Practice Management for Employed Physicians 8MedWest Health System Selects Allscripts Electronic Health Record and Practice Management for Employed Physicians 9MedWest Health System Selects Allscripts Electronic Health Record and Practice Management for Employed Physicians 10
(Date:5/23/2013)... May 23, 2013 The Rottenstein Law ... firm, has created the Tylenol Lawsuit Information Center at ... Tylenol users and those who are considering filing lawsuits. ... to potentially cause severe liver damage, according to a ... In the “safety communication,” the FDA warned consumers ...
(Date:5/23/2013)... Former United States Vice President Dick Cheney served ... Paramedic Luncheon. , In front of 1,500 guests ... medics, saying, "I am delighted to be here to ... of the Year Award. I think it's a tremendous ... within a company like this because there are obviously ...
(Date:5/23/2013)... York, NY (PRWEB) May 23, 2013 ... , Canadian tech start-ups are increasingly seeing their ... deals with larger US-based companies, according to new ... development engine. , The company has compiled its ... Borderless Investments. The findings of the research have shown ...
(Date:5/23/2013)... 2013 Parker Waichman LLP, a national ... injured by defective medical devices and drugs, is proud ... has been appointed Co-Lead Counsel in the Mirena IUD ... Litigation (Case 7:13-md-02434-CS). The Order, which was filed on ... to submit their proposal for the Court’s appointment of ...
(Date:5/23/2013)... Schools should ensure that kids get at least ... support their health and boost performance in school, ... previous studies show 60 minutes of vigorous to ... estimated that only about 50 percent of school-aged ... the report from the Institute of Medicine. ...
Breaking Medicine News(10 mins):Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2Health News:Acadian Ambulance Honors Paramedic of the Year at Annual Luncheon 2Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 2Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 3Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 4Health News:U.S. District Court Appoints Parker Waichman LLP’s Matthew J. McCauley to Leadership Role in Mirena IUD Litigation 2Health News:U.S. School Kids Should Get Hour of Exercise Daily: Report 2
... because of cost , , FRIDAY, May 30 (HealthDay News) -- ... in 2006, so 38 percent of high school graduates and ... in the year after graduation, a new report shows. , ... done the study, the number of uninsured has grown," said ...
... Completed, WASHINGTON, May 30 The Department of,Veterans ... to,veterans potentially identified as being ill or injured from ... begin targeting over 500,000 OEF-OIF veterans who have been,discharged ... health care., "We promised to reach out to ...
... 30 On June 5th at the annual ... vote for the,second year on a shareowner proposal ... The resolution received 42% last year., Walden ... on,integrating environmental, social and governance factors into the,investment ...
... be a good investment for the health, according to a ... death rate for golfers is 40 per cent lower than ... status, which correspond to a 5 year increase in life ... , It is a well-known fact that exercise is good ...
... German . , Viruses are true experts ... organism. This trait is now being exploited for gene therapy, ... patient to treat genetic diseases or genetic defects. Korean researchers ... journal Angewandte Chemie, they have been able to use it ...
... 38 Fule,Health & Advisory, LTD ("38 Fule", or ... has begun trading on the OTC market,s highest,tier, ... premier trading,quotation and disclosure venue for over-the-counter securities ... have reliable information and,disclosure., "As a member ...
Cached Medicine News:Health News:More Young People Going Without Health Insurance 2Health News:More Young People Going Without Health Insurance 3Health News:VA Begins Next Phase of Combat Vet Outreach 2Health News:Golf prolongs life 2Health News:Self-assembled viruses 2Health News:Xi'an 38 Fule Health & Advisory, LTD Lists on International OTCQX 2
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
... new Finnpipette Focus from Thermo ... combine ergonomics with uncompromising performance. ... plate offers a custom fit ... new shorter tip cones allow ...
... The new Finnpipette Focus from ... to combine ergonomics with uncompromising ... handle plate offers a custom ... The new shorter tip cones ...
... The microprocessor controlled, Blanketrol II ... system provides effective patient warming ... system! The Blanketrol II offers ... flow rates of any hyper-hypothermia ...
Medicine Products: